Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

Published September 2020 | Version v1.0.0
Journal Article Open

Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza

  • 1. ROR icon Northwestern University
  • 2. ROR icon Lurie Children's Hospital
  • 3. ROR icon Northwestern Memorial Hospital

Abstract

Background: The outbreak of coronavirus disease 2019 (COVID-19) in December 2019 overlaps with the flu season. Methods: We compared clinical and laboratory results from 719 influenza and 973 COVID-19 patients from January to April 2020. We compiled laboratory results from the first 14 days of the hospitalized patients using parameters that are most significantly different between COVID-19 and influenza and hierarchically clustered COVID-19 patients. Findings: Compared to influenza, patients with COVID-19 exhibited a continued increase in white blood cell count, rapid decline of hemoglobin, more rapid increase in blood urea nitrogen (BUN) and D-dimer, and higher level of alanine transaminase, C-reactive protein, ferritin, and fibrinogen. COVID-19 patients were sub-classified into 5 clusters through a hierarchical clustering analysis. Medical records were reviewed and patients were risk stratified based on the clinical outcomes. The cluster with the highest risk showed 27 8% fatality, 94% ICU admission, 94% intubation, and 28% discharge rates compared to 0%, 38%, 22%, and 88% in the lowest risk cluster, respectively. Patients in the highest risk cluster had leukocytosis including neutrophilia and monocytosis, severe anemia, increased red blood cell distribution width, higher BUN, creatinine, D-dimer, alkaline phosphatase, bilirubin, and troponin. Interpretation: There are significant differences in the clinical and laboratory courses between COVID-19 and influenza. Risk stratification in hospitalized COVID-19 patients using laboratory data could be useful to predict clinical outcomes and pathophysiology of these patients. (C) 2020 The Author(s). Published by Elsevier Ltd.

Other

original_citation: Mei Y, Weinberg SE, Zhao LH, Frink A, Qi C, Behdad A, Ji P. Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza. Eclinicalmedicine. 2020;26:8.

Files

1-s2.0-S2589537020302194-main.pdf
Files (4.1 MB)
Name Size Download all
md5:ab0287ee2bdcc833d5fef11fc170e987
4.1 MB Preview Download

Additional details

Created:
March 30, 2023
Modified:
September 20, 2023